Adição na publicação
#15.35
10/05/2021
RPI 2648
Application data
Number
112019009617Type
Filing
Publication
PCT
US2017064480 The application was abandoned: examination was not requested within the 36 months following the 12/04/2017 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.
Talk to a specialistLatest action published by the INPI: 10/05/2021. We update with every new RPI gazette, published weekly.
Applicants
ELI LILLY AND COMPANY
US
INNOVENT BIOLOGICS (SUZHOU) CO., LTD.
CN
Inventors
Y. L. (pessoa física)
US
Y. Z. (pessoa física)
US
IPC Classification
Priority claims
US
62/431,480 · 12/08/2016
Abstract
A presente invenção refere-se aos anticorpos que ligam a proteína-3 contendo o domínio de imunoglobulina e de mucina de células T humana (Tim-3) e podem ser úteis para o tratamento de tumores sólidos e hematológicos em combinação com anticorpos anti-PD-1 humana, quimioterapia e radiação ionizante.
Publications in the Brazilian Industrial Property Gazette (RPI).
#15.35
10/05/2021
RPI 2648
#11.1.1
06/01/2021
RPI 2630
#11.1
03/16/2021
RPI 2619
#1.3
08/13/2019
RPI 2536
#1.1
05/21/2019
RPI 2524
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.